Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, 5S ribosomal pseudogene 203 (RNA5SP203) is a non-coding RNA pseudogene classified in human genomic annotation projects as a nonfunctional copy of the 5S ribosomal RNA gene. Pseudogenes, including RNA5SP203, arise through duplication or reverse transcription events and may integrate into various genomic locations. They generally lack the capacity to encode functional RNA or protein products due to sequence disruptions or mutations. Unlike the functional 5S ribosomal RNA, which participates in ribosomal assembly and protein translation, RNA5SP203 lacks evidence for a biological activity and is not considered a therapeutic target. Its presence is primarily notable for genomic annotation and evolutionary analysis, not for molecular pharmacology, disease association, or drug development.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 5S ribosomal pseudogene 203 (RNA5SP203).